Sirtris Pharmaceuticals (SIRT) to Present at First Annual Boston Biotech R&D Conference  
10/17/2008 9:22:44 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sirtris, a GSK company focused on discovering and developing small molecule drugs to treat diseases of aging such as Type 2 Diabetes, today announced that it will provide an update on the Company’s clinical and preclinical progress at the 2008 Boston Biotech R&D Conference on Wednesday, October 22, 2008 at Harvard Medical School.